Stephen Basso
Directeur Financier/CFO chez INNOVIVA, INC.
Provenance du réseau au premier degré de Stephen Basso
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 93 | |
| Public Company | Pharmaceuticals: Major | 13 | |
| Public Company | Pharmaceuticals: Major | 7 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Stephen Basso via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Sales & Marketing Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| ARVINAS, INC. | Biotechnology | Director/Board Member Human Resources Officer General Counsel Director of Finance/CFO | |
| NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Compliance Officer | |
| ALLOVIR, INC. | Biotechnology | President Chairman General Counsel Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Compliance Officer | |
| Yale University | College/University | Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Corporate Officer/Principal | |
| DYNE THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Corporate Officer/Principal | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Chairman Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| Princeton University | College/University | Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| SAREPTA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer | |
| ARMATA PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| AMARIN CORPORATION PLC | Pharmaceuticals: Major | Chairman Corporate Officer/Principal Director/Board Member | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
ElevateBio LLC
 ElevateBio LLC BiotechnologyHealth Technology ElevateBio LLC is a biotechnology holding company, which creates and operates a broad portfolio of cell and gene therapy companies. It builds single and multi-product companies by providing scientific founders with bench-to-bedside capabilities including scientists, manufacturing facilities, drug developers, and commercial expertise. The company was founded by David L. Hallal, Vikas Sinha, and Mitchell H. Finer and is headquartered in Cambridge, MA. | Biotechnology | Founder Chief Executive Officer General Counsel | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| ABEONA THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Comptroller/Controller/Auditor | |
LifeEDIT Therapeutics, Inc.
 LifeEDIT Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of ElevateBio LLC, LifeEDIT Therapeutics, Inc. is a next-generation genome editing company that has built a highly innovative platform with one of the world's largest and most diverse collections of novel RNA-guided nucleases (RGNs) and base editors. The company offers gene editing tools with higher fidelity, novel functionality, reduced immune response risk, and easier delivery. LifeEDIT has a large and diverse library of RGNs, including type II and type V systems that encompass knock-out and knock-in capabilities, transcriptional regulation, and base editing when coupled with one of their proprietary deaminases. The company's nuclease collection has a broad range of protospacer adjacent motifs (PAMs), offering unprecedented access to genomes. LifeEDIT is headquartered in Morrisville, NC. The CEO of the company is Mitchell H. Finer. LifeEDIT Therapeutics was acquired by ElevateBio LLC from AgBiome Delta LLC on October 27, 2021. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| VOR BIOPHARMA INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
New Haven Pharmaceuticals, Inc.
 New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Pharmaceuticals: Major | Chief Administrative Officer Corporate Officer/Principal | |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Director/Board Member Sales & Marketing | |
| BAXALTA INC | Biotechnology | Chief Executive Officer Public Communications Contact | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Sales & Marketing Comptroller/Controller/Auditor | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| INSEAD | College/University | Undergraduate Degree Masters Business Admin | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
eGenesis, Inc.
 eGenesis, Inc. Miscellaneous Commercial ServicesCommercial Services eGenesis, Inc. operates research platform to deliver human transplantable cells, tissues, and organs grown in pigs. It uses gene editing technology such as CRISPR to directly address the key virology and immunology hurdles that have impeded xenotransplantation. The company was founded by George M. Church, Yang Luhan, Prashant Mali, Geoff Mackay and Guell Marc in 2015 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director of Finance/CFO | |
| CHEMOMAB THERAPEUTICS LTD. | Biotechnology | Chairman Director/Board Member | |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Q32 Bio, Inc.
 Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Director/Board Member | |
| PLIANT THERAPEUTICS, INC. | Biotechnology | Director/Board Member Comptroller/Controller/Auditor | |
Gemini Therapeutics Sub, Inc.
 Gemini Therapeutics Sub, Inc. BiotechnologyHealth Technology Gemini Therapeutics Sub, Inc. engages in the development of treatments for age-related macular degeneration (AMD) and linked ocular disorders. Its multimodal pipeline includes monoclonal antibodies, recombinant proteins and gene therapies. The company was founded by James McLaughlin, Johanna Seddon, Paul Barlow and Andrew Herbert in 2015 and is headquartered in Cambridge, MA. | Biotechnology | Chairman Chief Executive Officer | |
SpringWorks Therapeutics LLC
 SpringWorks Therapeutics LLC BiotechnologyHealth Technology SpringWorks Therapeutics, Inc. engages in the development of biopharmaceutical products for patients with severe rare diseases and cancer. It focuses in advancing the pipeline of standalone and combination therapies with an initial focus on rare diseases and oncology. The company was founded by Lara S. Sullivan in 2017 and is headquartered in Stamford, CT. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Undergraduate Degree | |
VectivBio AG
 VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Director/Board Member Corporate Officer/Principal |
Statistiques
Internationale
| Etats-Unis | 42 |
| Suisse | 3 |
| Israël | 3 |
| Royaume-Uni | 2 |
| Irlande | 2 |
Sectorielle
| Health Technology | 42 |
| Consumer Services | 5 |
| Commercial Services | 4 |
| Finance | 2 |
Opérationnelle
| Director/Board Member | 380 |
| Corporate Officer/Principal | 295 |
| Independent Dir/Board Member | 150 |
| Undergraduate Degree | 86 |
| Chairman | 68 |
Relations les plus connectées
| Insiders | |
|---|---|
| Stephen P. Squinto | 40 |
| Ann Margaret Veneman | 34 |
| Felix Baker | 28 |
| Max E. Link | 28 |
| Martin MacKay | 28 |
| Jules Haimovitz | 27 |
| William Keller | 26 |
| Christopher Coughlin | 23 |
| Abbie Celniker | 23 |
| M. Burns | 23 |
| Sapna R. Srivastava | 22 |
| Dave Anderson | 21 |
| Robert Hopfner | 20 |
| David Brennan | 19 |
| Warren W. Wasiewski | 19 |
- Bourse
- Insiders
- Stephen Basso
- Connexions Sociétés
